Kwai Poon

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

C. Brightling, R. Faggioni, E. Piper, 2012, European Respiratory Journal.

Phase 2 randomized, double-blind, placebo-controlled study of tralokinumab, an anti-IL-13 monoclonal antibody, in moderate to severe asthma

C. Brightling, R. Faggioni, E. Piper, 2011 .